...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Liquidity

Does anyone have points of view on the downsides and benefits of Zenith Capital or Zenith Epigenetics (wholly owned by ZCC) being listed on a public exchange at this stage?

Thanks

Toinv

Share
New Message
Please login to post a reply